US Pharma MarketingCartesian secures funding to
Cartesian’s $150M financing; Editas Medicine’s money moves Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA…
💰 Cartesian Therapeutic’s $150M financing: The Maryland biotech secured $50 million in an initial tranche from K2 HealthVentures. The credit facility will help the company “accelerate” its commercial launch work in ...
Source: Endpoints News